• UGI USER
  • Dec 13, 2023
  • 30 Likes
  • 0 Comments

POMPE DISEASE:

Why in the News?

  • Nidhi Shirol, India’s first Pompe disease patient, passed away at 24 after a prolonged battle with the condition, spending the last six years semi-comatose.
  • Her father, Prasanna Shirol, established the Organisation for Rare Diseases India, the country’s pioneer NGO for rare diseases.
Source: Org. of Rare Disease India

About Pompe Disease:

  • Known as Glycogen Storage Disease Type II, Pompe disease is a rare genetic disorder caused by a deficiency of the enzyme acid alpha glucosidase (GAA), vital for glycogen breakdown in cell lysosomes.
  • Prevalence estimates range from 1 in 40,000 to 1 in 300,000 births, showcasing varied onset ages and severity levels leading to diverse clinical manifestations.

Key Symptoms:

  • Muscle Weakness: Progressive muscle weakness is prominent, affecting respiratory muscles and causing breathing difficulties, especially while lying down.
  • Motor Skill Delays: Children might experience delays in achieving motor milestones like sitting, crawling, and walking.
  • Respiratory Complications: Weakening respiratory muscles leads to breathlessness and infections.
  • Hypertrophic Cardiomyopathy: Thickening of heart muscles can impair heart functions.

Diagnosis and Treatment:

  • Diagnostic Methods: Enzyme assays measure GAA activity, while genetic testing identifies responsible GAA gene mutations crucial for confirmation.
  • Management: Although no cure exists, treatments like Enzyme Replacement Therapy can enhance the patient’s quality of life by reducing glycogen build-up through enzyme infusion.

This succinctly outlines Pompe disease, its symptoms, diagnostic methods, and available management options, underscoring the importance of early detection and intervention despite the absence of a definitive cure.